GRAPHITE BIO INC
GRAPHITE BIO INC logo
GRPH

GRAPHITE BIO INC (GRPH)

$3.432.83%

Market is closed
– opens on 8 PM, 02 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$3.2819
Day's Range
$3.535
$2.07
52-Week Range
$13.39
1 month return2.0%
3 month return3.63%
1 year return61.33%
5 year return85.99%

Company Information

Graphite Bio is a clinical-stage, next-generation gene editing company harnessing high efficiency targeted gene integration to develop a new class of therapies to potentially cure a wide range of serious and life-threatening diseases. Graphite Bio is pioneering a precision gene editing approach that could enable a variety of applications to transform human health through its potential to achieve one of medicine’s most elusive goals: to precisely “find & replace” any gene in the genome. Graphite Bio’s platform allows it to precisely correct mutations, replace entire disease-causing genes with normal genes or insert new genes into predetermined, safe locations. The company was co-founded by academic pioneers in the fields of gene editing and gene therapy, including Maria Grazia Roncarolo, M.D., and Matthew Porteus, M.D., Ph.D.
OrganizationGRAPHITE BIO INC
Employees114
CEODr. Joshua Lehrer-Graiwer FACC, M.D.
IndustryElectronics Distributors

Analyst Recommendation

based on 14 analysts ratings

Buy
78%
Buy
21%
Hold
0%
Sell

Based on 14 Wall street analysts offering stock ratings for GRAPHITE BIO INC(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 241.4%

Current

$3.43

Target

$11.71

Recommendation Trend

Based on 14 analyst

Current1M Ago3M Ago
Buy
11
10
10
Hold
3
3
3
Sell
0
0
0
Consensus
BUY
BUY
BUY

Highlights

Market Capitalization
199.5M
Book Value
$5.44
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
5.18
PE Ratio
0.66
Wall Street Target Price
11.71

Valuation

Trailing PE0.66
Forward PE0.0
Price/Book (mrq)
0.62
Enterprise Value
-86960123
Enterprise Value/Revenue
0.0
Enterprise Value/Ebitda
0.82

Technicals

50 Day MA
3.33
200 Day MA
4.06

Institutional Holdings

Samsara BioCapital, LLC

14.55%

FMR Inc

8.99%

EcoR1 Capital, LLC

2.72%

Avidity Partners Management LP

2.71%

Citadel Advisors Llc

2.27%

Vanguard Group Inc

2.06%

Discover more

Frequently Asked Questions

What is GRAPHITE BIO INC share price today?

Can Indians buy GRAPHITE BIO INC shares?

How can I buy GRAPHITE BIO INC shares from India?

Can Fractional shares of GRAPHITE BIO INC be purchased?

What are the documents required to start investing in GRAPHITE BIO INC stocks?

What are today’s High and Low prices of GRAPHITE BIO INC?

What are today’s traded volumes of GRAPHITE BIO INC?

What is today’s market capitalisation of GRAPHITE BIO INC?

What is the 52 Week High and Low Range of GRAPHITE BIO INC?

How much percentage GRAPHITE BIO INC is down from its 52 Week High?

How much percentage GRAPHITE BIO INC is up from its 52 Week low?

What are the historical returns of GRAPHITE BIO INC?

Who is the Chief Executive Officer (CEO) of GRAPHITE BIO INC?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*